FACT Insider Trading Activity and SEC Form 4 Filings
FACT insider trading summary
No open-market insider purchases or sales of Facet Biotech Corp (FACT) have been reported on SEC Form 4 in the past 12 months.
Latest FACT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 20, 2010 | Laboratories Abbott | 10% Owner | Buy | $1.69B (62,652,055 @ $27.00) |
| Apr 20, 2010 | Amber Acquisition Inc. | 10% Owner | Buy | $1.69B (62,652,055 @ $27.00) |
| Feb 9, 2010 | Biotechnology Value Fund L P | Insider | Buy | $173K (11,000 @ $15.69) |
| Feb 9, 2010 | Bvf Inc/Il | 10% Owner | Buy | $47K (3,000 @ $15.69) |
| Feb 9, 2010 | Bvf Investments LLC | Insider | Buy | $78K (5,000 @ $15.69) |
| Feb 9, 2010 | Bvf Investments LLC | Insider | Buy | $47K (3,000 @ $15.69) |
| Feb 9, 2010 | Mark N Lampert | 10% Owner | Buy | $78K (5,000 @ $15.69) |
| Feb 9, 2010 | Bvf Partners L P/Il | 10% Owner | Buy | $78K (5,000 @ $15.69) |
| Feb 9, 2010 | Biotechnology Value Fund II LP | Insider | Buy | $47K (3,000 @ $15.69) |
| Feb 9, 2010 | Biotechnology Value Fund II LP | Insider | Buy | $173K (11,000 @ $15.69) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.